SUNNYVALE, Calif., Oct. 19, 2020 /PRNewswire/ -- Accuray
Incorporated (NASDAQ: ARAY) announced today it has appointed
Mike Leischer as its vice president
and general manager, Americas (AMS) region, effective immediately.
In this role, he will provide leadership of the AMS region
commercial teams, driving development and implementation of a
business strategy designed to achieve the Company's strategic,
financial and operational objectives for the region. Mr. Leischer
will report to Suzanne Winter, chief
commercial officer and senior vice president, R&D.
Mr. Leischer is recognized for his ability to deliver consistent
financial results, profitable share growth and prestigious new
business wins in highly competitive healthcare markets. He brings
more than 23 years of sales, strategy and management experience,
most recently with Canon Medical Systems USA. During his tenure with Canon, Mr.
Leischer held executive level positions as vice president of
strategic business solutions and strategic business groups. His
responsibilities ranged from developing and managing strategic
solutions and partnerships, which increased early visibility and
market share across the company's diagnostic imaging portfolio, to
driving revenue growth and building executive relationships within
the federal government, GPOs, IDNs, and academic medical centers.
Mr. Leischer also held various leadership positions of increasing
responsibility at GE Healthcare, including general manager, Pacific
Northwest, where he had P&L responsibility across all GE
Healthcare product and service lines in the region.
"We are extremely pleased to welcome Mike Leischer to the Accuray team. Mike is
joining Accuray at the best time in the company's history from a
product portfolio perspective and we look forward to his
contributions to the achievement of our long-term growth and
profitability goals," said Josh H.
Levine, president and chief executive officer of Accuray.
Mike has a proven track record for building strategic partnerships
across a range of stakeholders, making him an ideal choice for the
vice president and general manager, AMS region."
"On behalf of the Accuray team, I would like to extend a warm
welcome to Mike. We are thrilled to have the opportunity to
leverage his commercialization expertise to expand access to our
cutting-edge radiation therapy treatment technologies within this
important region," said Suzanne
Winter, chief commercial officer and senior vice president,
R&D at Accuray. "Accuray is committed to providing our
customers with innovative solutions that empower them to meet the
full spectrum of patient needs including the delivery of
ultra-hypofractionated radiotherapy treatments advanced by the
CyberKnife® and TomoTherapy® platforms.
Mike's combination of leadership and experience is exactly what we
need to grow our business in the AMS region and take Accuray to the
next level."
About Accuray
Accuray Incorporated (Nasdaq: ARAY) develops, manufactures and
sells radiotherapy systems that are intended to make cancer
treatments shorter, safer, personalized and more effective,
ultimately enabling patients to live longer, better lives. Our
radiation treatment delivery systems in combination with
fully-integrated software solutions set the industry standard for
precision and cover the full range of radiation therapy and
radiosurgery procedures. For more information, please visit
www.accuray.com or follow us on Facebook, LinkedIn, Twitter and
YouTube.
Safe Harbor Statement
Statements made in this press release that are not statements of
historical fact are forward-looking statements and are subject to
the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements in this press
release relate, but are not limited, to expectations regarding the
company's products, growth and profitability. These forward-looking
statements involve risks and uncertainties. If any of these risks
or uncertainties materialize, or if any of the company's
assumptions prove incorrect, actual results could differ materially
from the results expressed or implied by these forward-looking
statements.
These risks and uncertainties include, but are not limited to,
risks related to the effect of the COVID-19 pandemic, or the
perception of its effects, on the company's operations and the
operations of its customers and suppliers; the company's ability to
achieve widespread market acceptance of its products, including new
product offerings; and such other risks identified under the
heading "Risk Factors" in the company's Annual Report on Form 10-K,
filed with the Securities and Exchange Commission (the "SEC")
on August 25, 2020, and as updated
periodically with the company's other filings with the SEC.
Forward-looking statements speak only as of the date the
statements are made and are based on information available to the
company at the time those statements are made and/or management's
good faith belief as of that time with respect to future events.
The company assumes no obligation to update forward-looking
statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking
information, except to the extent required by applicable securities
laws. Accordingly, investors should not put undue reliance on any
forward-looking statements.
Investor Contact:
Joe Diaz
Investor Relations, Lytham Partners
+1 (602) 889-9700
diaz@lythampartners.com
Media Contact:
Beth
Kaplan
Accuray
+1 (408)
789-4426
bkaplan@accuray.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/accuray-appoints-mike-leischer-vice-president-and-general-manager-americas-region-301154395.html
SOURCE Accuray Incorporated